The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Warning over popular medication. Picture ... research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line pain killer for long ...

The Food and Drug Administration (FDA) hasn’t approved any medications containing CBD for pain relief, and additional research is necessary to determine CBD’s ability to reduce pain ...

However, when we asked, the doctor said that’s all she would prescribe (other than a similar narcotic) but that if he preferred, he could instead take over-the-counter medications like Tylenol or ...

trastuzumab as adjuvant treatment for patients with HER2-positive earlier breast cancer found to have residual invasive breast cancer at surgery. The trial included 1,486 women with HER2-positve ...